Eira M, Araujo M, Seguro AC (August 2006). “Urinary NO3 excretion and renal failure in indinavir-treated patients”. 《Brazilian Journal of Medical and Biological Research》 39 (8): 1065–70. doi:10.1590/s0100-879x2006000800009. PMID16906281.
Shankar SS, Dubé MP, Gorski JC, Klaunig JE, Steinberg HO (November 2005). “Indinavir impairs endothelial function in healthy HIV-negative men”. 《American Heart Journal》 150 (5): 933.e1–933.e7. doi:10.1016/j.ahj.2005.06.005. PMID16290967.
Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, 외. (September 1997). “Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy”. 《The New England Journal of Medicine》 337 (11): 734–9. doi:10.1056/nejm199709113371102. PMID9287228.
Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, 외. (September 1997). “A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team”. 《The New England Journal of Medicine》 337 (11): 725–33. doi:10.1056/nejm199709113371101. PMID9287227.
Capaldini L (August 1997). “Protease inhibitors' metabolic side effects: cholesterol, triglycerides, blood sugar, and "Crix belly." Interview with Lisa Capaldini, M.D. Interview by John S. James”. 《AIDS Treatment News》 (277): 1–4. PMID11364559.
Eira M, Araujo M, Seguro AC (August 2006). “Urinary NO3 excretion and renal failure in indinavir-treated patients”. 《Brazilian Journal of Medical and Biological Research》 39 (8): 1065–70. doi:10.1590/s0100-879x2006000800009. PMID16906281.
Shankar SS, Dubé MP, Gorski JC, Klaunig JE, Steinberg HO (November 2005). “Indinavir impairs endothelial function in healthy HIV-negative men”. 《American Heart Journal》 150 (5): 933.e1–933.e7. doi:10.1016/j.ahj.2005.06.005. PMID16290967.
Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, 외. (September 1997). “Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy”. 《The New England Journal of Medicine》 337 (11): 734–9. doi:10.1056/nejm199709113371102. PMID9287228.
Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, 외. (September 1997). “A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team”. 《The New England Journal of Medicine》 337 (11): 725–33. doi:10.1056/nejm199709113371101. PMID9287227.
pubchem.ncbi.nlm.nih.gov
Pubchem. “Indinavir”. 《pubchem.ncbi.nlm.nih.gov》 (영어). 2018년 10월 22일에 확인함.
Pubchem. “Indinavir”. 《pubchem.ncbi.nlm.nih.gov》 (영어). 2018년 10월 22일에 확인함.
livertox.nih.gov
“Indinavir”. 《livertox.nih.gov》. 2018년 10월 21일에 확인함.